Upon changing tides in financial markets, regulatory, federal funding, investor weariness and healthcare reform, the life sciences industry is experiencing significant change. The aim, of course, is to inject new life — and capital — into a sector at best defined as ‘holding steady’ during the recession, and at worst ‘moribund’.
Aftab Jamil, Partner with BDO, Partner and National Leader for the Technology and Life Sciences Practice at BDO, is an expert in helping EGCs navigate financing rounds. Aftab spoke with OneMedTV during the 6th Annual OneMedForum in January to discuss the state of life sciences investment, and how companies can formulate new strategies to attract a sustainable class of investors. At the core of these new strategies are the initiatives being implemented to increase access to non-venture capital in the earlier rounds, which may incubate a company long enough to grow a pipeline, attract tenable/diverse revenue opportunity, and eventually reach market.
For more materials discussing early stage financing and changing tides, visit the OneMedPlace Educational Module.
For more than 100 years, BDO USA has been recognized as a premier accounting, tax, financial advisory and consulting organization. Providing services to a wide range of publicly traded and privately held companies, BDO offers a sophisticated array of services and global capabilities, combined with the personal attention of experienced and committed professionals.
BDO serves clients through more than 41 offices and over 400 independent alliance firm locations nationwide. As an independent Member Firm of BDO International Limited, BDO serves multinational clients through a global network of 1,118 offices in 135 countries. BDO USA, LLP, a Delaware limited liability partnership, is the US member of BDO International Limited, a UK company limited by guarantee, and forms part of the international BDO network of independent member firms. BDO is the brand name for the BDO network and for each of the BDO Member Firms.